16-1210082-G-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_021098.3(CACNA1H):​c.3792G>T​(p.Gln1264His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000665 in 1,559,858 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00067 ( 3 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.408
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015750557).
BP6
Variant 16-1210082-G-T is Benign according to our data. Variant chr16-1210082-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 529635.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=1, Uncertain_significance=1}. Variant chr16-1210082-G-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000591 (90/152330) while in subpopulation AMR AF= 0.00196 (30/15310). AF 95% confidence interval is 0.00141. There are 0 homozygotes in gnomad4. There are 40 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 90 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.3792G>T p.Gln1264His missense_variant Exon 18 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.3792G>T p.Gln1264His missense_variant Exon 18 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000565831.6 linkc.3792G>T p.Gln1264His missense_variant Exon 17 of 33 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000638323.1 linkc.3753G>T p.Gln1251His missense_variant Exon 18 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000569107.5 linkc.15G>T p.Gln5His missense_variant Exon 1 of 17 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000564231.5 linkc.15G>T p.Gln5His missense_variant Exon 1 of 18 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000562079.5 linkc.15G>T p.Gln5His missense_variant Exon 1 of 17 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000637236.2 linkn.155G>T non_coding_transcript_exon_variant Exon 2 of 6 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.3792G>T non_coding_transcript_exon_variant Exon 18 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*1705G>T non_coding_transcript_exon_variant Exon 18 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000640028.1 linkn.*1705G>T 3_prime_UTR_variant Exon 18 of 35 5 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.000591
AC:
90
AN:
152212
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000706
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.000679
AC:
113
AN:
166482
Hom.:
0
AF XY:
0.000661
AC XY:
59
AN XY:
89236
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000172
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000892
Gnomad OTH exome
AF:
0.000660
GnomAD4 exome
AF:
0.000674
AC:
948
AN:
1407528
Hom.:
3
Cov.:
34
AF XY:
0.000646
AC XY:
449
AN XY:
695280
show subpopulations
Gnomad4 AFR exome
AF:
0.000157
Gnomad4 AMR exome
AF:
0.00163
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000176
Gnomad4 FIN exome
AF:
0.0000207
Gnomad4 NFE exome
AF:
0.000738
Gnomad4 OTH exome
AF:
0.00101
GnomAD4 genome
AF:
0.000591
AC:
90
AN:
152330
Hom.:
0
Cov.:
33
AF XY:
0.000537
AC XY:
40
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.00196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000706
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.000682
Hom.:
0
Bravo
AF:
0.000824
ESP6500AA
AF:
0.000242
AC:
1
ESP6500EA
AF:
0.00109
AC:
9
ExAC
AF:
0.000360
AC:
41

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Apr 14, 2023
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Observed in several unrelated patients with seizures and in one unaffected parent; however, other genes associated with seizures were not sequenced in these individuals (Heron et al., 2007); Functional studies showed that this variant did not alter channel properties (Heron et al., 2007); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28488083, 17696120, 31217264) -

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Oct 08, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Nov 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.072
T
BayesDel_noAF
Uncertain
0.11
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.22
T;.;.;.
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.72
T;T;T;.
MetaRNN
Benign
0.016
T;T;T;T
MetaSVM
Uncertain
0.22
D
MutationAssessor
Uncertain
2.6
M;.;M;M
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.9
N;.;N;N
REVEL
Pathogenic
0.69
Sift
Benign
0.11
T;.;T;T
Sift4G
Benign
0.10
T;.;T;T
Polyphen
0.61
P;.;P;P
Vest4
0.20
MutPred
0.77
Gain of helix (P = 0.0325);.;Gain of helix (P = 0.0325);Gain of helix (P = 0.0325);
MVP
0.98
ClinPred
0.080
T
GERP RS
1.7
Varity_R
0.12
gMVP
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200228767; hg19: chr16-1260082; API